Toying With Line Extensions to Generate Revenues: Have the Big Pharmas Lost Their Way?
The traditional heavyweights or big pharmas of the modern pharmaceutical industry are facing unprecedented challenges, primarily, in the form of drying product pipelines, expiry of patents of blockbuster drugs and swiftly declining margins on existing products. While service provision for revenue g...
| Main Author: | |
|---|---|
| Format: | Dissertation (University of Nottingham only) |
| Language: | English |
| Published: |
2009
|
| Online Access: | https://eprints.nottingham.ac.uk/23360/ |